Bladder (Urothelial, Transitional Cell) Cancer Resectable (Pre-Cystectomy)
specific2
Centers
0
Active Trials
—
Cancer Funding
Top Centers for Bladder (Urothelial, Transitional Cell) Cancer Resectable (Pre-Cystectomy)(2)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | Stanford Cancer InstitutePalo Alto, CA NCI Comprehensive | 75.0 |
| 2 | Karmanos Cancer InstituteDetroit, MI NCI Comprehensive | 75.0 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →